Mark Hill

Mark Hill is an Associate Director and technology and strategy lead in Research Technologies at GSK, bringing twenty-one years of experience in drug discovery within the pharmaceutical industry. They possess extensive laboratory skills and knowledge in genetically altered in vivo models and central nervous system (CNS) diseases, with a specific focus on cognition and translational assays. Mark has a proven track record in designing and establishing CNS disease-relevant models and has experience in project management and line management. Prior to their current role, they held positions at GSK and Takeda Cambridge, contributing to key developments in early-stage projects and therapeutic assays. Mark earned a Bachelor of Science in Physiology & Pharmacology with industrial experience from the University of the West of England.